Who are Alesta's investors?

Alesta's investors include Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, Frazier Healthcare Partners, MPM BioImpact, RTW Investments L.P., Thuja Capital.

Alesta

Founded 2021 · 21 employees on LinkedIn · 7 known investors

Find your way into Alesta

165 people in our graph share verified history with the Alesta team — schools, employers, funds. One of them is your warm intro.

Sebastian Bernalesunlockedknows Matthias Van Woensel · together at Alesta (overlapped)

×9knows the team · via Droia Ventures

×2knows the team · via Université libre de Bruxelles

Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology. The biotech company works on early-stage drug development and clinical research.

Biotech Healthtech

Founders & leadership

Ilan GanotCEO

Benit MaruCMO

Matthias Van Woensel CSOMatthias Van Woensel is Chief Scientific Officer at Alesta Therapeutics, a biotech company developing therapies for rare genetic diseases and oncology. He previously served as a partner at DROIA Ventures, an investment firm focused on oncology and genetic disease opportunities.

Investors · 7

Droia Ventureslisted by Droia VenturesLuxembourg · $540K

How we know: Droia Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · Not right? Tell us

Novartis Venture Fundlisted by Novartis Venture FundBasel · $5M – $25M

How we know: Novartis Venture Fund's portfolio page · funding news · Not right? Tell us

Frazier Healthcare PartnersreportedSeattle · $50M – $400M

How we know: a partner's Signal profile · funding news · Not right? Tell us

MPM BioImpactreportedBoston · $1M – $15M

How we know: a partner's Signal profile · Not right? Tell us

RTW Investments L.P.reportedNew York

How we know: funding news · Not right? Tell us

Thuja CapitalreportedUtrecht

How we know: funding news · Not right? Tell us

Frequently asked questions

What does Alesta do?: Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology. The biotech company works on early-stage drug development and clinical research.
Who are Alesta's investors?: Alesta's investors include Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, Frazier Healthcare Partners, MPM BioImpact, RTW Investments L.P., Thuja Capital.